Use of Isatuximab, Dexamethasone and Lenalidomide in a Go-Slow Fashion for Ultra-Frail Patients With Multiple Myeloma

NCT06517017 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma
Plasma Cell Leukemia

Interventions

DRUG: Isatuximab

Sponsor

University of Utah

Collaborators

[object Object]